Development and validation of new assay method for the simultaneous analysis of diltiazem, metformin, pioglitazone and rosiglitazone by RP-HPLC and its applications in pharmaceuticals and human serum

Journal of Chromatographic Science

Volumn 49, Issue 10, 2011, Pages 774-779

  Sultana, Najma ^a   Arayne, M Saeed ^a   Shafi, Nighat ^a   Siddiqui, Farhan Ahmed ^a   Hussain, Azhar ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81455143151     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chrsci/49.10.774     Document Type: Article

References (33)

1. J.C. Pickup and G.Williams. "Hypertension and diabetes mellitus". Textbook of Diabetes. Oxford: Blackwells, 719-720, 1991.
2. E. Erdmann.Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes. Int. J. Cardiol. 107(2): 152-158 (2006). (Pubitemid 43075227)
3. Curtis Triplitt. Drug interactions of medications commonly used in diabetes. Diabetes Spectrum 19(4): 202-211 (2006). (Pubitemid 44885518)
4. B.M.Y. Cheung. Blockade of the renin-angiotensin system. HKMJ. 8(3): 185-191 (2002). (Pubitemid 34665734)
5. Certain Blood Pressure-lowering Drugs Reduce Diabetes Risk In Hispanic Patients. Science Daily (May 22, 2006).
6. B. Steven. Leichter and stephanie thomas combination medications in diabetes care: An opportunity that merits more attention. Clinical Diabetes 21: 175-178 (2003).
7. L.H. Lindholm, H Ibsen B. Dahlof R.B. Devereux, G. Beevers, U. de Faire, F. Fyhrquist, S. Julis, S.E. Kjeldsen, K. Kristiansson, O. Lederballe-Pedersen, M.S. Nieminem, P. Omvik, S. Oparil, H. Wedel, P. Aurup, J. Edelman, and S. Snapinn. The LIFE Study Group. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet. 359: 1004-1010 (2002). (Pubitemid 34286537)
8. D.J. Abraham. Burger's Medicinal Chemistry and Drug Discovery, JohnWiley and Sons, Inc., Publication Hoboken, New Jersey, 6th 3: 15-17 (2003).
9. A.R. Gennaro. Remington: The Science and Practice of Pharmacy. University of the Sciences in Philadelphia 21st Ed, Philadelphia, PA 1364-1365 (2005).
10. E. Erdmann.Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes. Internat. J. Cardiology 15:107(2) 152-158 (2005).
11. G.J. Vergote, C. Vervaet, J.P. Remon, T. Haemers, and F. Verpoort. Near-infrared FT-Raman spectroscopy as a rapid analytical tool for the determination of diltiazem hydrochloride in tablets. Eur. J. Pharm. Sci. 16: 63-67 (2002). (Pubitemid 34756783)
12. B. Chankvetadze, M. Saito, E. Yashima, and Y. Okamoto. Enantioseparation using selected polysaccharides as chiral buffer additives in capillary electrophoresis. J. Chromatogr. A 773: 331-338 (1997). (Pubitemid 27279984)
13. M. Akram El-Didamony. Indirect spectrophotometric determination of diltiazem hydrochloride in pure form and pharmaceutical formulations. Central European Sci. J. 3(3): 520-536 (2005).
14. P.M. Lacroix, N. Beaulieu, T.D. Cyr, and E.G. Lovering. High performance liquid chromatography methods for assay of diltiazem hydrochloride and its compounds in bulk drug and finish tablet. J. Pharm. Sci. 78: 243-246 (1989). (Pubitemid 19079851)
15. Z. Dragica, S. Traje, and S. Marina. High-performance liquid chromatographic determination of diltiazem in human plasma after solid-phase and liquid-liquid extraction. Anal Bioanal. Chem. 376: 843-853 (2003).
16. L.X. Zhang and Z. Feilang. HPLC determination of diltiazem in human plasma and its application to pharmacokinetics in humans. Biomed. Chromatogr. 17(8): 522-525 (2003).
17. R. Shimizu, K. Ishii,N. Tsumagari,M. Tanigawa, andM.Matsumoto. Determination of optical isomers in diltiazem hydrochloride by high-performance liquid chromatography. J. Chromatogr A. 253: 101-108 (1982). (Pubitemid 13149143)
18. R. Shimizu, T. Kakimoto, K. Ishii, Y. Fujimoto, H. Kishi and N. Tsumagari. New derivatization reagent for the resolution of optical isomers in diltiazem hydrochloride by high-performance liquid chromatography. J. Chromatogr A. 357: 119-125 (1986). (Pubitemid 16083674)
19. K. Ishii, K. Minato, N. Nishimura, T. Miyamoto, and T. Sato. Direct chromatographic resolution of four optical isomers of diltiazem hydrochloride on a Chiralcel OF column. J. Chromatogr. A 686(1): 93-100 (1994).
20. B.S.Madhira,D.M. Vaibhav, A.S.Dimal, K.B. Kashyap, S.M. Rajendra, G. Madhira, J.P. Binita. Estimation of pioglitazone hydrochloride and metformin hydrochloride in tablets by derivative spectrophotometry and liquid chromatographic methods. J. AOAC Internat. 88(4): 1167-1172 (2005).
21. T. Radhakrishna, R.D. Sreenivas, and R.G. Om. Determination of pioglitazone hydrochloride in bulk and pharmaceutical formulations by HPLC and MEKC methods. J. Pharmaceut. Biomed. Anal. 29(4): 593-607 (2002). (Pubitemid 34687015)
22. P. Venkatesh, T. Harisudhan, H. Choudhury, R. Mullangi, N.R. Srinivas. Simultaneous estimation of six anti-diabetic drugs - glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide, and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay. Biomed. Chromatogr. 20(10): 1043-1048 (2006). (Pubitemid 44697042)
23. D.G. Sankar, J.M.R. Kumar, and M.V.V.N. Reddy. UV spectrophotometric methods for the determination of anti-diabetic drugs. Asian J. Chem. 16(1): 537-539 (2004).
24. R. Bhushan, D. Gupta, and A. Jain. TLC supplemented by UV spectrophotometry compared with HPLC for separation and determination of some antidiabetic drugs in pharmaceutical preparations. J. Planar Chromatogr.Modern TLC, 19:(110) 288-296 (2006). (Pubitemid 44462958)
25. B.L. Kolte, B.B. Raut, A.A. Deo, M.A. Bagool, and D.B. Shinde. Simultaneous high-performance liquid chromatographic determination of pioglitazone and metformin in pharmaceutical-dosage form. J. Chromatogr. Sci. 42(1): 27-31 (2004).
26. B.L. Kolte, B.B. Raut, A.A. Deo, M.A. Bagool, and D.B. Shinde. Simultaneous determination of metformin in combination with rosiglitazone by reversed-phase liquid chromatography. J. Chromatogr. Sci. 42(2): 70-73 (2004).
27. N. Zaltýne, E. Ucakturk. Simultaneous determination of ezetimibe and simvastatin in pharmaceutical formulations by dual-mode gradient LC. Chromatographia. 66: S87-S91 (2007). (Pubitemid 47437244)
28. K. Suenami, L.W. Lim, T. Takeuchi, Y. Sasajima, K. Sato, Y. Takekoshi, and S. Kanno. Rapid and simultaneous determination of nonsteroidal anti-inflammatory drugs in human plasma by LC-MS with solid-phase extraction. Anal Bioanal Chem 384: 1501-1505 (2006).
29. G.S. Clarke. The validation of analytical methods for drug substances and drug products in UK pharmaceutical laboratories. J. Pharm. Biomed. Anal. 12: 643 (1994).
30. ICH guideline Q2B: Validation of Analytical Procedures: Methodology (2003).
31. I. Krull andM. Swartz. Validation viewpoint, introduction: National and international guidelines. LC-GC 15(6): 534-539 (1997).
32. R.L. Plackett and J.P. Burman. The design of optimummulti-factorial experiments. Biometrika. 33: 305-325 (1943-1946).
33. E. ASTM. American Society for Testing and Materials. Standard Guide for Conducting Ruggedness Tests (Plackett-Burman Design). 100 Barr Harbor Drive,West Conshohcken PA 19428-2959.